Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$499M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
Amazon
AMZN
|
+$286M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$248M |
| 2 |
LPT
Liberty Property Trust
LPT
|
+$148M |
| 3 |
Procter & Gamble
PG
|
+$122M |
| 4 |
Visa
V
|
+$92.4M |
| 5 |
MDCO
Medicines Co
MDCO
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Scholar Rock
SRRK
$6.47B
| $3.06M | ﹤0.01% |
252,448
+15,986
| +7% | +$215K |
|
2427
UBS Group
UBS
$176B
| $3.06M | ﹤0.01% |
329,920
+107,624
| +48% | +$1.24M |
|
2428
FirstService
FSV
$6.29B
| $3.04M | ﹤0.01% |
39,391
+1,977
| +5% | +$190K |
|
2429
BioXcel Therapeutics
BTAI
$27M
| $3.03M | ﹤0.01% |
8,474
+3,524
| +71% | +$1.27M |
|
2430
KALA BIO
KALA
$14.1M
| $3.03M | ﹤0.01% |
138
+3
| +2% | +$47.9K |
|
|
CBPO
2431
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $3.02M | ﹤0.01% |
28,002
-4
| -0% | -$460 |
|
|
CAJ
2432
DELISTED
Canon, Inc.
CAJ
| $3.01M | ﹤0.01% |
138,995
+37,995
| +38% | +$957K |
|
2433
DXP Enterprises
DXPE
$3.16B
| $3M | ﹤0.01% |
244,460
+21,314
| +10% | +$615K |
|
|
CIVI
2434
DELISTED
Civitas Resources
CIVI
| $2.99M | ﹤0.01% |
265,696
+7,499
| +3% | +$126K |
|
2435
SmartFinancial
SMBK
$899M
| $2.99M | ﹤0.01% |
196,527
+17,578
| +10% | +$345K |
|
|
CPE
2436
DELISTED
Callon Petroleum Company
CPE
| $2.98M | ﹤0.01% |
544,819
+40,211
| +8% | +$990K |
|
|
ALBO
2437
DELISTED
Albireo Pharma Inc
ALBO
| $2.98M | ﹤0.01% |
182,286
+40,073
| +28% | +$881K |
|
|
CNCE
2438
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.98M | ﹤0.01% |
337,280
+73,780
| +28% | +$728K |
|
|
AGNT
2439
AGNT Inc
AGNT
$705M
| $2.97M | ﹤0.01% |
702,162
+70,180
| +11% | +$358K |
|
|
GNTY
2440
DELISTED
Guaranty Bancshares
GNTY
| $2.96M | ﹤0.01% |
140,980
+9,892
| +8% | +$260K |
|
2441
Green Brick Partners
GRBK
$3.13B
| $2.96M | ﹤0.01% |
368,059
+31,229
| +9% | +$331K |
|
|
NVO
2442
Novo Nordisk
NVO
$208B
| $2.96M | ﹤0.01% |
98,308
+9,806
| +11% | +$292K |
|
2443
Minerva Neurosciences
NERV
$207M
| $2.96M | ﹤0.01% |
61,387
+3,882
| +7% | +$234K |
|
|
SYRS
2444
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.95M | ﹤0.01% |
49,819
+2,264
| +5% | +$154K |
|
2445
Bridgewater Bancshares
BWB
$589M
| $2.95M | ﹤0.01% |
302,887
+19,489
| +7% | +$239K |
|
2446
Pan American Silver
PAAS
$21.6B
| $2.95M | ﹤0.01% |
206,113
+34,357
| +20% | +$714K |
|
|
CNR
2447
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $2.95M | ﹤0.01% |
647,642
+14,891
| +2% | +$111K |
|
2448
Caleres
CAL
$480M
| $2.95M | ﹤0.01% |
567,483
+45,088
| +9% | +$648K |
|
2449
XBiotech
XBIT
$69.5M
| $2.94M | ﹤0.01% |
276,658
-59,821
| -18% | -$974K |
|
2450
Transcat
TRNS
$896M
| $2.93M | ﹤0.01% |
110,525
+8,337
| +8% | +$250K |
|
Similar funds
Geode Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Geode Capital Management held 4,292 positions worth $384B, down 20% from $478B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geode Capital Management's Q1 2020 filing shows 103 new, 3,113 increased, 564 reduced and 177 closed positions. Its largest new stake was Perdoceo Education: 1,042,040 shares worth $11.2M. The largest sale was Wellcare Health Plans, Inc., an estimated $248M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2020 buy was Perdoceo Education: 1,042,040 shares worth $11.2M.
- Geode Capital Management added most to Apple in Q1 2020, an estimated $499M increase.
- Geode Capital Management's biggest Q1 2020 reduction was Procter & Gamble, cutting an estimated $122M.
- Geode Capital Management fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $248M.
- Geode Capital Management's ten largest holdings make up 21% of its $384B portfolio in Q1 2020.
- Geode Capital Management opened 103 new positions and closed 177 in Q1 2020.
- Geode Capital Management's portfolio value fell 20% quarter-over-quarter to $384B.
Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.